Treatment with unfunded drugs in oncology: the impact of access programmes and clinical trials-Reference-Cited by-同舟云学术

Treatment with unfunded drugs in oncology: the impact of access programmes and clinical trials

Published:2013-01 Issue:1 Volume:43 Page:23-31
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Tie J.¹²³,Gibbs P.¹²³⁴

Affiliation:

1. Department of Medical Oncology; the Royal Melbourne Hospital

2. Department of Medical Oncology; Western Hospital

3. Ludwig Colon Cancer Initiative Biomarkers Laboratory; Ludwig Institute for Cancer Research

4. BioGrid Australia; Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.2012.02750.x/fullpdf

Reference23 articles.

1. AIHW (Australian Institute of Health and Welfare) and AACR (Australasian Association of Cancer Registries) Cancer in Australia: an overview, 2008 Canberra AIHW 2008

2. Systemic therapy for colorectal cancer;Meyerhardt;N Engl J Med,2005

3. The price tag on progress - chemotherapy for colorectal cancer;Schrag;N Engl J Med,2004

4. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia;PLOS ONE;2021-11-29

2. Demonstrating the feasibility of collecting secondary, de‐identified data on Australian patients receiving treatment as part of a Medicine Access Programme;Internal Medicine Journal;2020-01

3. Medicines access programs to cancer medicines in Australia and New Zealand: An exploratory study;Health Policy;2018-03

4. Author reply;Internal Medicine Journal;2013-07

5. Co-funded expanded access programmes for new oncology drugs: creating a two-tier system for Australian cancer patients?;Internal Medicine Journal;2013-07